➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Harvard Business School
Dow
AstraZeneca
McKinsey

Last Updated: October 22, 2021

DrugPatentWatch Database Preview

TICLOPIDINE HYDROCHLORIDE Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

Drug patent expirations by year for TICLOPIDINE HYDROCHLORIDE
Recent Clinical Trials for TICLOPIDINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Kafrelsheikh UniversityPhase 2/Phase 3
Janssen Research & Development, LLCPhase 1
Merck Sharp & Dohme Corp.Phase 2

See all TICLOPIDINE HYDROCHLORIDE clinical trials

US Patents and Regulatory Information for TICLOPIDINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth TICLOPIDINE HYDROCHLORIDE ticlopidine hydrochloride TABLET;ORAL 075253-001 Aug 20, 1999 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Sun Pharm Inds Inc TICLOPIDINE HYDROCHLORIDE ticlopidine hydrochloride TABLET;ORAL 075526-001 Sep 26, 2002 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Chartwell Rx TICLOPIDINE HYDROCHLORIDE ticlopidine hydrochloride TABLET;ORAL 075326-001 Aug 20, 1999 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Teva TICLOPIDINE HYDROCHLORIDE ticlopidine hydrochloride TABLET;ORAL 075149-001 Aug 20, 1999 AB RX No Yes ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Apotex TICLOPIDINE HYDROCHLORIDE ticlopidine hydrochloride TABLET;ORAL 075089-001 Jul 1, 1999 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Chartwell Rx TICLOPIDINE HYDROCHLORIDE ticlopidine hydrochloride TABLET;ORAL 075318-001 Aug 20, 1999 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Mylan TICLOPIDINE HYDROCHLORIDE ticlopidine hydrochloride TABLET;ORAL 075316-001 Nov 2, 1999 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Harvard Business School
Dow
AstraZeneca
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.